August 21, 2025 Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit read more
August 11, 2025 Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference read more
CTAD 2024 Quanterix Fireside Chat with Henrik Zetterburg: Advances in Blood-Based Biomarkers for Alzheimer’s Disease read more
PharmaExec.com October 8, 2025 Translating Complex Scientific Findings into Actionable Insights read more
SelectScience October 6, 2025 AI and the rise of blood-based biomarkers heralds new era for neurological diagnostics read more
R&D World August 20, 2025 Quanterix Wins 2025 R&D 100 Award for Simoa BD-Tau Advantage PLUS Assay read more
October 9, 2025 Built for Translation: Why Simoa Stands Alone in Clinical-Grade Biomarker Measurement read more
September 8, 2025 YKL-40 Emerges as a Key Indicator of Neuroinflammatory-Driven Tau Pathology and Brain Atrophy in Alzheimer’s Disease read more